Based in Waltham, Massachusetts, Accellient Partners is a team of drug development experts with extensive experience in regulatory affairs and scientific research. They offer a fully integrated approach to product development, from late discovery through IND submission and Phase 2. Their development model leverages technology and business experience to minimize program risks, lower costs, and accelerate development timelines. Accellient also assists in the capital raising process and supports manufacturing requirements and nonclinical development needs. They work with clients in all markets and offer an extensive network of expert affiliates, KOLs, and service providers. Accellient strives to be the biopharmaceutical and investment industries’ virtual drug development partner of choice.